Enoximone

No authors listed

Review

No authors listed. Lancet. 1988.

. 1988 May 14;1(8594):1085-6.

No abstract available

Similar articles

Treatment of heart failure with enoximone, a new phosphodiesterase inhibitor. Düsseldorf, Federal Republic of Germany. September 25-27, 1987. Proceedings.
[No authors listed] [No authors listed] J Cardiovasc Pharmacol. 1989;14 Suppl 1:S1-S83. J Cardiovasc Pharmacol. 1989. PMID: 2480479 No abstract available.
[Enoximone].
Ventura G. Ventura G. Medicina (Firenze). 1990 Apr-Jun;10(2):191-3. Medicina (Firenze). 1990. PMID: 2148796 Clinical Trial. Italian.
Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT, Janicki JS, Jain MC. Weber KT, et al. J Heart Transplant. 1986 Mar-Apr;5(2):105-12. J Heart Transplant. 1986. PMID: 2956397
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
Colucci WS, Wright RF, Braunwald E. Colucci WS, et al. N Engl J Med. 1986 Feb 6;314(6):349-58. doi: 10.1056/NEJM198602063140605. N Engl J Med. 1986. PMID: 2418353 Review. No abstract available.
[Tolerance of enoximone in patients with heart failure].
Gilfrich HJ, Dieterich HA. Gilfrich HJ, et al. Z Kardiol. 1991;80 Suppl 4:93-7. Z Kardiol. 1991. PMID: 1833904 Review. German.

Clinical pharmacology and therapeutics.
Kendall MJ, Horton RC. Kendall MJ, et al. Postgrad Med J. 1990 Mar;66(773):166-85. doi: 10.1136/pgmj.66.773.166. Postgrad Med J. 1990. PMID: 2194187 Free PMC article. Review. No abstract available.